A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
Zhao F, Olkhov-Mitsel E, Kamdar S, Jeyapala R, Garcia J, Hurst R, Hanna MY, Mills R, Tuzova AV, O'Reilly E, Kelly S, Cooper C; Movember Urine Biomarker Consortium; Brewer D, Perry AS, Clark J, Fleshner N, Bapat B.
Zhao F, et al. Among authors: kamdar s.
Clin Epigenetics. 2018 Nov 23;10(1):147. doi: 10.1186/s13148-018-0575-z.
Clin Epigenetics. 2018.
PMID: 30470249
Free PMC article.